NanoBio® to Report Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium
09:58 EDT 24 Sep 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
NanoBio®
Corporation announced today it will present data from three
preclinical studies at the 8th
Annual International Respiratory Syncytial Virus (RSV) Symposium
taking place from Sept. 27-30 in Santa Fe, N.M.
...
Other Sources for this Article
Schwartz MSL
Benjamin Navon, 781-684-0770
nanobio@schwartzmsl.com
More From BioPortfolio on "NanoBio® to Report Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
